Katie Shen
@kaytea196
she/her | @nyulangone GI fellow, @ClevelandClinic IM, @JeffersonUniv MD
ID:542223219
01-04-2012 01:37:57
242 Tweets
329 Followers
434 Following
The Only Way To Spray: The Most Optimized Way to Deliver Hemospray
No bonewax needed, uses CO2 in scope and catheter, no clogging, allows suctioning, and improves “white out”. Costs <10$. Most of the set up is done before Hemospray kit is ever opened.
#GITwitter
Such fun project to do with my sister!
Thanks ClinicalLiverDisease for the invitation!
Keep beta blocking and carry on!
Juan Turnes Juan G Abraldes Brett E Fortune MD AASLD
#livertwitter
journals.lww.com/cld/fulltext/2…
Endoscopic Tissue Sampling
▪️Esophagus
▪️Stomach
▪️Small intestine
▪️Colon
▪️Miscellaneous
Here’s another version I compiled.
Note: overall low quality of evidence for each recommendation, but this can be nice guidance for early endoscopists.
#GITwitter
this algorithm on restarting anti-TB meds in patients with presumed drug-induced hepatitis (from the NYC Bureau of TB Control) is phenomenal and pragmatic! nychealthy
Vintage Quick Tips on esophageal variceal bleeding 🩸by Adam Winters Lizzie Aby, MD
✨From risk factors and outcomes to medical and endoscopic management, it'a all here (with carvedilol now the preferred B-blocker!
aasld.org/liver-fellow-n…
This week's most viewed article:
AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: ow.ly/Loo550QgWo8
By authors from VUMC Department of Medicine, Mayo Clinic, and The Warren Alpert Medical School
#Hpylori #PPI #antibiotics
🔥🔥 Emoroid Digest 🔥🔥
When to use linaclotide? Prucalopride? As it is constipation awareness month, be sure to check out Dr. Veeramachaneni’s (Hima V) visual summary on the American Gastroenterological Association (AGA) & ACG practice guideline on CIC with an easy to use reference table!
Great review on LIVER TRANSPLANTATION in the NEJM by Lucey, Furuya & Foley:
🔸Indications
🔸Assessment
🔸Current trends & challenges
#livertwitter #MedTwitter AASLD EASL Education
shorturl.at/pMPQ1
Great results from the first clinical trial testing NALTREXONE vs placebo in alcohol-related cirrhosis, today at #TLM23 :
🔸Naltrexone is well tolerated
🔸It favors abstinence
🔸It reduces by 50% new onset decompensation
AASLD #livertwitter #MedTwitter ILBS_University